Procalcitonin

How and Why to Utilize Procalcitonin in the Midst of COVID-19

ACCREDITATION EXPIRED - Program content available for information only.

ACCREDITATION EXPIRED - Program content available for information only. Join Dr. Jim Neuenschwander as he hosts Dr. Michael Broyles and Dr. Eric Gluck in an informative discussion of the role of procalcitonin biomarker testing to help direct anti-infective therapy in the face of COVID-19 infections. The need to continue to rapidly assess patients and initiate the most appropriate therapy, whether antiviral or antimicrobial is even more critical as the continue to be severe issues of overcrowding in hospital Emergency Departments and Critical Care Units.

How and Why to Utilize Procalcitonin in the Midst of COVID-19